Eidos Therapeutics, Inc. EBITDA 2018-2020 | EIDX
Eidos Therapeutics, Inc. ebitda from 2018 to 2020. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Eidos Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2019 | $-40 |
| 2018 | $-37 |
| 2017 | $-12 |
| 2016 | $-2 |
| Eidos Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2020-09-30 | $-29 |
| 2020-06-30 | $-28 |
| 2020-03-31 | $-23 |
| 2019-12-31 | $-19 |
| 2019-09-30 | $6 |
| 2019-06-30 | $-15 |
| 2019-03-31 | $-13 |
| 2018-12-31 | $-10 |
| 2018-09-30 | $-12 |
| 2018-06-30 | $-8 |
| 2018-03-31 | $-7 |
| 2017-12-31 | $-5 |
| 2017-09-30 | $-3 |
| 2017-06-30 | $-2 |
| 2017-03-31 | $-2 |
